← back to search

David R. Macdonald

Health Canada · CA
Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Radiomics and Machine Learning in Medical Imaging, and Neuroblastoma Research and Treatments.
h-index
40
citations
14,243
works
139
NIH funding
primary concept
Medicine
email

Recent publications

Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice
The Lancet Oncology 2024cited by 24position: middledoi
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
Journal of Clinical Oncology 2023cited by 426position: middledoi
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas
Cell Reports Medicine 2023cited by 6position: middledoi
Barriers to accrual and enrollment in brain tumor trials
Neuro-Oncology 2019cited by 80position: middledoi
Association of<i>MGMT</i>Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide
JAMA Oncology 2018cited by 201position: middledoi
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group
Neuro-Oncology 2018cited by 53position: middledoi
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria
Neuro-Oncology 2017cited by 241position: middledoi
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
The Lancet Oncology 2017cited by 105position: middledoi
Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
The Lancet Oncology 2017cited by 56position: middledoi
Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131
Journal of Neuro-Oncology 2015cited by 32position: middledoi
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group
The Lancet Oncology 2013cited by 141position: middledoi
Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy
Current Neurology and Neuroscience Reports 2013cited by 133position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Martin J. van den Bent · St James's University Hospital6 papers (2013–2023)Patrick Y. Wen · Harvard University6 papers (2013–2023)Minesh P. Mehta · Carbon Engineering (Canada)6 papers (2013–2023)Michael A. Vogelbaum · Erasmus University Rotterdam6 papers (2013–2023)Riccardo Soffietti · European Institute of Oncology4 papers (2013–2017)Jeffrey S. Wefel · The University of Texas MD Anderson Cancer Center3 papers (2013–2017)Eudocia Q. Lee · Center for Neuro-Oncology3 papers (2013–2017)Nancy U. Lin · San Francisco Art Institute3 papers (2013–2017)David A. Reardon · Massachusetts Institute of Technology3 papers (2017–2023)Timothy F. Cloughesy · UCLA Medical Center3 papers (2013–2023)David M. Peereboom · Advocate Health Care3 papers (2015–2017)John H. Suh · Texas A&M University3 papers (2013–2017)Susan M. Chang · Moffitt Cancer Center3 papers (2013–2017)Lisa M. DeAngelis · Universidad Católica de Santa Fe2 papers (2017–2018)Steven N. Kalkanis · Henry Ford Health System2 papers (2013–2017)Janet Dancey · Queen's University2 papers (2013–2017)Michael Weller · Center for Neurosciences2 papers (2018–2023)Evanthia Galanis · Mayo Clinic2 papers (2017–2023)David Schiff · University of Virginia2 papers (2013–2017)Hidefumi Aoyama · Sapporo Medical University Hospital2 papers (2013–2017)